Showing results (111-120 of 250) with videos related to

Sort By:
Pageof 25
Blood|April 2, 2014
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AMLJeffrey E Lancet, Jorge E Cortes, Donna E Hogge, et al.
Leukemia|February 25, 2025
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasmNadia Gharaee, Joanna Wegrzyn-Woltosz, Jihong Jiang, et al.
Oncotarget|November 16, 2017
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapyThomas Prebet, Thomas Cluzeau, Sophie Park, et al.
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry|August 9, 2021
Stereoselective Synthesis of (4S,5S)-5-Vinyloxazolidin-2-one-4-carboxylate as a β-Vinylserine Synthetic Equivalent by Vinyl Grignard Addition to an N-Tosyl Version of Garner's AldehydeErnest G Nolen, Yuqi M Cao, Brynn D Lewis, et al.
Leukemia Research|September 15, 2009
Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemiaSteven L Allen, Jonathan E Kolitz, Ante S Lundberg, et al.
Leukemia Research|May 18, 2007
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interfaceFriedrich Wimazal, Christa Fonatsch, Renate Thalhammer, et al.
Leukemia Research|September 17, 2011
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDSPeter Valent, Barbara J Bain, John M Bennett, et al.
Blood Cancer Journal|February 2, 2022
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patientsAbhishek A Mangaonkar, Terra L Lasho, Rhett P Ketterling, et al.
Blood|August 24, 2012
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Ramon V Tiu, Rami Komrokji, et al.
Leukemia & Lymphoma|October 21, 2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486)Peter H Wiernik, Peter A Cassileth, Traci Leong, et al.
Pageof 25